The cardiovascular health supplements market has seen considerable growth due to a variety of factors.
• The cardiovascular health supplements market has expanded rapidly in recent years. It is expected to grow from $13.11 billion in 2024 to $14.78 billion in 2025, at a compound annual growth rate (CAGR) of 12.7%.
This growth is driven by a shift toward less invasive surgeries, a rise in demand for structural heart devices, ongoing healthcare professional training, increased healthcare expenditure, and heightened awareness of heart health.
The cardiovascular health supplements market is expected to maintain its strong growth trajectory in upcoming years.
• The cardiovascular health supplements market is expected to grow to $23.57 billion by 2029, with a CAGR of 12.4%.
Growth is attributed to the aging population, increasing awareness about heart health, screening programs, favorable reimbursement policies, and timely regulatory approvals. Key trends include collaborations, real-world evidence, product launches, preventive interventions, and innovations in supplements.
The rising prevalence of heart-related diseases is expected to propel the growth of the cardiovascular health supplements market. The growing occurrence of cardiovascular diseases is linked to factors like inactivity, poor diet, and smoking. Cardiovascular health supplements support heart function, especially for individuals with heart conditions. The Minnesota Department of Health’s September 2024 report highlighted that approximately 30% of adults in the state have high blood pressure. The increased incidence of cardiovascular diseases is driving the demand for heart health supplements.
The cardiovascular health supplements market covered in this report is segmented –
1) By Type: Natural Supplements, Synthetic Supplements
2) By Ingredient: Vitamins And Minerals, Herbs And Botanicals, Omega Fatty Acids, Coenzyme Q10 (CoQ
10), Other Ingredients
3) By Form: Liquid, Tablet, Capsules, Softgels, Powder, Others Forms
4) By Distribution Channel: Offline, Online
Subsegments:
1) By Natural Supplements: Omega-3 Fatty Acids, Coenzyme Q10 (CoQ
10), Garlic Extract, Green Tea Extract, Flaxseed Oil, Hawthorn Extract, Turmeric Or Curcumin, Pomegranate Extract
2) By Synthetic Supplements: Statins (Cholesterol-Lowering Agents), Synthetic Omega-3 Fatty Acids, Phytosterols, L-Arginine, Synthetic Antioxidants, Beta-Glucan
In the cardiovascular health supplements market, companies are focusing on natural products like dispersible phytosterols to lower cholesterol levels. Dispersible phytosterols help manage cholesterol by dissolving easily in water. For instance, in September 2023, Nutrartis launched Cardiosmile, a liquid supplement containing water-dispersible phytosterols. This product aids in cholesterol management and supports overall heart health, promoting long-term cardiovascular wellness.
Major companies operating in the cardiovascular health supplements market are:
• Pfizer Inc.
• Johnson & Johnson
• Amway Corporation
• Herbalife Nutrition Ltd.
• General Nutrition Centers Inc. (GNC)
• NOW Health Group Inc.
• Garden of Life LLC
• Thorne Healthtech Inc.
• Jarrow Formulas Inc.
• Life Extension
• Designs for Health Inc.
• Gaia Herbs Inc.
• Schiff Nutrition International
• MegaFood LLC
• Twinlab Consolidated Holdings Inc.
• New Chapter Inc.
• Integrative Therapeutics LLC
• Pure Encapsulations LLC
• Doctor's Best Inc.
• Nature's Bounty Co.
• Solgar Inc.
• Renew Life Formulas LLC
• Nature Made Nutritional Products
• Source Naturals Inc
Asia-Pacific was the largest region in the cardiovascular health supplements market in 2023. The regions covered in the cardiovascular health supplements market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.